Bayer MaterialScience LLC (BMS) has unveiled the flame retardant (FR) polycarbonate/ABS blend, Bayblend® M301 FR for use in the health care market, specifically for surface device applications contacting intact skin. The resin, company says, meets Food and Drug Administration (FDA) ISO 10993-5 for cytotoxicity, and ISO 10993-10 for irritation and sensitization testing requirements. Potential applications include insulin pumps and respiratory devices, among others. The resin is supplied in pellet form for injection molding applications and is available in opaque gray. Other opaque colors that utilize biocompatibility tested colorants can also be formulated. The flame-retardant additive to this grade is antimony-, bromine-, and chlorine-free.
"The material's combination of physical properties, flame retardance and compliance with these three ISO biocompatibility standards provides medical device and equipment manufacturers with an added safety factor and increased confidence. This, in turn, may potentially streamline the approval process so they are able to bring life-saving products to market more quickly," said Kevin Dunay, market segment leader, Medical Polycarbonates NAFTA, BMS.
12-Feb-09 
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}